)
Edge17 Oct 2025
A Castle in the Sky: The Story of Oracle
Oracle's journey from database innovator to disciplined enterprise backbone, now shaping the AI buildout with a standardized cloud infrastructure.
bioMérieux (BIM) investor relations material
bioMérieux Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary4 Sep, 2025
Executive summary
Achieved 9.4% organic sales growth in H1 2025, reaching €2,044 million, led by molecular diagnostics, industrial applications, and double-digit gains in BIOFIRE® and SPOTFIRE® panels.
Profitability improved with CEBIT/EBIT up 21.5% to €372 million and margin rising to 18.2% of sales, reflecting efficiency gains from strategic initiatives.
Free cash flow more than tripled to €170 million, supported by EBITDA growth and working capital improvements.
Net income declined 25% to €161 million due to a €146 million impairment on Reveal technology.
Multiple new product launches, strategic acquisitions, and progress on CSR objectives, including significant GHG emissions reduction.
Financial highlights
Net sales reached €2,044 million, up 9.4% at constant exchange rates, with gross margin improving to 57.1% (+80bps) and EBITDA at €495 million (24.2% of sales).
CEBIT/EBIT margin rose to 18.2% (+210bps), and free cash flow increased to €170 million.
Net income, group share, was €161 million, down 25% due to the Reveal impairment; excluding this, net income was up 45%.
SG&A costs rose 7.7%, including an €8 million one-off for the MyShare employee plan.
CapEx stable at 7.5% of sales, focused on US and French manufacturing and installed base expansion.
Outlook and guidance
2025 organic sales growth guidance revised to 6–7.5% due to China market decline; CEBIT/EBIT growth guidance raised to 12–18%.
Tariff impacts estimated at €5–10 million in 2025 and €35 million in 2026, with mitigation actions underway.
FX impact on 2025 CEBIT/ROCC estimated at –€25 million.
CapEx guidance lowered to 9% of sales for the year.
What specific factors drive China's sales decline?
Detail the strategic implications of Reveal impairment.
Assess SPOTFIRE®'s net impact on H1 profitability.
China market decline: 2026 impact?
Sustained EBIT margin growth drivers?
VITEK Reveal: path to commercial success?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next bioMérieux earnings date
Q3 2025 TU4 Nov, 2025
Next bioMérieux earnings date
Q3 2025 TU4 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research17 Oct 2025
Beneath the Surface: A Conversation with Epiroc CEO Helena Hedblom
Legacy, innovation, and leading one of Sweden's most influential industrial companies into a new era.
)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Frequently asked questions
bioMérieux S.A. is a global biotechnology company that specializes in the development, manufacturing, and marketing of in vitro diagnostic solutions for medical and industrial applications. The company’s products include diagnostic tools for infectious diseases, oncology, cardiovascular diseases, and food safety testing. bioMérieux offers a range of systems, reagents, and software designed for microbiology, immunoassays, and molecular biology, helping healthcare providers and laboratories detect pathogens and analyze biological samples. The company also serves industrial markets, providing solutions for food safety, pharmaceutical quality control, and environmental monitoring. The company is headquartered in Marcy-l'Étoile, France, and its shares are listed on Euronext Paris.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage